Literature DB >> 34326303

Usefulness of Hydrastis for the prevention of encrustation of long-term indwelling catheters in persons with neurogenic bladder dysfunction: a case series.

Jürgen Pannek1, Susanne Pannek-Rademacher2.   

Abstract

INTRODUCTION: Virtually every person with a spinal cord injury (SCI) suffers from a neurogenic lower urinary tract dysfunction (NLUTD). In the long term, about 15% of persons with SCI depend on indwelling (suprapubic or transurethral) catheters for bladder management. About 50% of these patients suffer from catheter encrustation and blockage, which may become a vital threat for persons with SCI, as it can lead to septicemia or autonomic dysreflexia. Until today, no prophylaxis of catheter encrustations with an evidence-based proof of efficacy exists. CASE
PRESENTATION: The homeopathic remedy Hydrastis, made from the goldenseal root, is used for the treatment of thick, mucous urine sediment. In four patients with tetraplegia (three female, one male) who managed NLUTD by suprapubic catheters, recurrent encrustations and catheter blockage occurred despite irrigation and medical treatment. Surgical urinary diversion was envisioned. Applying Hydrastis C30 once weekly as a long-term medication, in three of the four patients, catheter obstructions ceased, with a follow-up for at least 1 year. One patient is awaiting ileal conduit surgery. DISCUSSION: According to the results of our case series, the application of Hydrastis seems to be beneficial in the prevention of encrustations of indwelling catheters in patients with SCI. As the treatment was effective and well tolerated, the problem is frequent, and effective solutions are scarce, a prospective trial seems justified.
© 2021. The Author(s), under exclusive licence to International Spinal Cord Society.

Entities:  

Mesh:

Year:  2021        PMID: 34326303      PMCID: PMC8322421          DOI: 10.1038/s41394-021-00433-2

Source DB:  PubMed          Journal:  Spinal Cord Ser Cases        ISSN: 2058-6124


  23 in total

1.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

2.  To clamp or not to clamp? Bladder management by suprapubic catheterization in patients with neurogenic bladder dysfunction.

Authors:  Jürgen Pannek; Konrad Göcking; Ulf Bersch
Journal:  World J Urol       Date:  2010-01-05       Impact factor: 4.226

3.  Does the valve regulated release of urine from the bladder decrease encrustation and blockage of indwelling catheters by crystalline proteus mirabilis biofilms?

Authors:  N A Sabbuba; D J Stickler; M J Long; Z Dong; T D Short; R J C Feneley
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

Review 4.  Bacterial biofilm and associated infections.

Authors:  Muhsin Jamal; Wisal Ahmad; Saadia Andleeb; Fazal Jalil; Muhammad Imran; Muhammad Asif Nawaz; Tahir Hussain; Muhammad Ali; Muhammad Rafiq; Muhammad Atif Kamil
Journal:  J Chin Med Assoc       Date:  2017-10-15       Impact factor: 2.743

5.  An electrified catheter to resist encrustation by Proteus mirabilis biofilm.

Authors:  Aniruddha Chakravarti; Santha Gangodawila; Michael James Long; Nicola S Morris; Alexander Robert Eadie Blacklock; David J Stickler
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

6.  Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients.

Authors:  J W Warren; W C Anthony; J M Hoopes; H L Muncie
Journal:  JAMA       Date:  1982-07-23       Impact factor: 56.272

7.  A tolerability and patient acceptability pilot study of a novel antimicrobial urinary catheter for long-term use.

Authors:  Katherine Belfield; Helen Betts; Richard Parkinson; Roger Bayston
Journal:  Neurourol Urodyn       Date:  2018-10-23       Impact factor: 2.696

8.  Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology.

Authors:  Jan Groen; Jürgen Pannek; David Castro Diaz; Giulio Del Popolo; Tobias Gross; Rizwan Hamid; Gilles Karsenty; Thomas M Kessler; Marc Schneider; Lisette 't Hoen; Bertil Blok
Journal:  Eur Urol       Date:  2015-08-22       Impact factor: 20.096

9.  Bladder management in individuals with chronic neurogenic lower urinary tract dysfunction.

Authors:  J Krebs; J Wöllner; J Pannek
Journal:  Spinal Cord       Date:  2015-11-10       Impact factor: 2.772

Review 10.  Recent evidence regarding triclosan and cancer risk.

Authors:  Michael T Dinwiddie; Paul D Terry; Jiangang Chen
Journal:  Int J Environ Res Public Health       Date:  2014-02-21       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.